Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network.
Martino
Steve
S
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06519, USA. steve.martino@yale.edu
Brigham
Gregory S
GS
Higgins
Christine
C
Gallon
Steve
S
Freese
Thomas E
TE
Albright
Lonnetta M
LM
Hulsey
Eric G
EG
Krom
Laurie
L
Storti
Susan A
SA
Perl
Harold
H
Nugent
Cathrine D
CD
Pintello
Denise
D
Condon
Timothy P
TP
D002047:Buprenorphine / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods; D003153:Community Health Services / Q000379:methods / Q000458:organization & administration; D006801:Humans; D033181:Information Dissemination / Q000379:methods*; D007406:Interview, Psychological / Q000379:methods; D009042:Motivation; D009292:Narcotic Antagonists / Q000627:therapeutic use; D054577:National Institute on Drug Abuse (U.S.); D055818:Public-Private Sector Partnerships / Q000458:organization & administration*; D016320:Substance Abuse Treatment Centers / Q000379:methods* / Q000458:organization & administration; D019966:Substance-Related Disorders / Q000534:rehabilitation*; D018581:Technology Transfer; D014481:United States
D009292:Narcotic Antagonists; D002047:Buprenorphine